Maravai Lifesciences Holdings, Inc. engages in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm’s brands include TriLink BioTechnologies, Cygnus, Glen Research, and Alphazyme. It operates through the TriLink and Cygnus segments. The TriLink segment manufactures and sells products used in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Cygnus segment sells biologic safety testing products and highly specialized analytical products for use in biologic manufacturing process development, including custom product-specific antibody and assay development services. It also operates through the following geographical segments: North America, Asia Pacific, Europe, the Middle East, and Africa, and Latin and Central America. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
435
Frequently Asked Questions
What is Market Cap of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A market cap is $1.01B.
What is the 52-week high for Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A 52 week high is $4.11 as of May 08, 2026.
What is the 52-week low for Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A 52 week low is $1.95 as of May 08, 2026.
What is Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price today?
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price today is $4.83.
What was Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price yesterday?
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price yesterday was $3.94.
What is the PE ratio of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A's P/E ratio is -4.35.
What is the Price-to-Book ratio of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A P/B ratio is 2.696.
What is the 50-day moving average of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A 50-day moving average is $3.36.
How many employees does Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A have?
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A has 435 employees.